Archives
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Fig shows three results generated from the
2018-11-12

Fig. 11 shows three results generated from the same two-floor architectural program that contains 13 rooms. The variety of results implies that the automated layout optimization can assist architects during the conceptual design process by providing them numerous results within a short time. The th
-
Cranial fasciitis is a well circumscribed nonencapsulated tu
2018-11-12

Cranial fasciitis is a well-circumscribed, nonencapsulated tumor with spindle rosmarinic acid in a nodular pattern with proliferation of fibroblasts and myofibroblasts. The histological characteristics of cranial fasciitis consist of dense areas of proliferated spindle or stellate-shape fibroblasts
-
Recommended treatment for intracranial mesenchymal chondrosa
2018-11-12

Recommended treatment for intracranial mesenchymal chondrosarcoma is radical surgical excision if possible. Preoperative embolization has been suggested because the tumor is highly vascular. Recurrence is common after resection, however. Some authors therefore recommend adjuvant radiation therapy to
-
Surgery and targeted molecular therapy are the two
2018-11-12

Surgery and targeted molecular therapy are the two gold standards for GISTs. Surgery is the first choice if a complete resection is possible. Imatinib is indicated for treating patients with KIT-positive (i.e., CD117-positive) unresectable and/or metastatic GISTs. For KIT-mutant proteins, imatinib i
-
mibefradil manufacturer The mesh has to be tailored in accor
2018-11-12

The mesh has to be tailored in accordance with the size and shape of the defect; fortunately, the malleability of the titanium material facilitates restoration of symmetric orbital socket conformation in three dimensions. It is still necessary to move the mesh plate in and out repetitively from the
-
Although the prognosis of resected esophageal cancer
2018-11-12

Although the prognosis of resected esophageal cancer has improved over the last decade, long-term survival remains poor. A large-scale study on the CRM involvement was performed by Dexter et al, who analyzed a cohort of 135 potentially curative esophagectomies. They demonstrated that CRM involvement
-
The insidiousness of its presentation and the
2018-11-12

The insidiousness of its presentation and the fact that buy GSK2656157 patients may maintain bowel transit usually delay the diagnosis of Richter\'s hernia. The time span from the onset of symptoms to operation is called preoperative delay. An increase in the delay increases the risk of ischemia an
-
Ureteral stones are the most common causes
2018-11-12

Ureteral stones are the most common causes of spontaneous ureteral rupture. Most patients received ureteroscopy and double-J stenting. Conservative management with TAK-242 manufacturer can also have a favorable outcome. Most patients experience a sudden onset of abdominal or flank pain. Spontaneous
-
br Regulation of Nrf activation The core of
2018-11-12

Regulation of Nrf2 activation The core of the Nrf2 regulation is Keap1. Keap1 functions as a negative regulator of Nrf2 by promoting ubiquitination and proteasomal degradation of Nrf2 [15]. Since Keap1 has highly reactive sulfhydryl groups in its cysteine residues, it is considered as a sensor fo
-
br Conclusions Sitosterol d glucoside and
2018-11-12

Conclusions β-Sitosterol-d-glucoside (1) and five condensed tannin fractions (2, 3, 4, 5, and 6) were isolated from the leaves of Q. phillyraeoides. The α-glucosidase inhibitory and antioxidant activities of the isolated constituents were investigated. Four antioxidant assays were successfully co
-
br Materials and methods br Results br Discussion Obesity re
2018-11-12

Materials and methods Results Discussion Obesity results when caloric intake exceeds energy expenditure, with an increase in adipocyte size or adipocyte number (Bjorntorp, 1974; Faust et al., 1978; Johnson et al., 1971, 1978; Yu et al., 1997). In the context of adipogenesis, development app
-
br Materials and methods br Results br Discussion Obesity re
2018-11-12

Materials and methods Results Discussion Obesity results when caloric intake exceeds energy expenditure, with an increase in adipocyte size or adipocyte number (Bjorntorp, 1974; Faust et al., 1978; Johnson et al., 1971, 1978; Yu et al., 1997). In the context of adipogenesis, development app
-
Introduction The degree to which embryonic stem cells ESCs r
2018-11-12

Introduction The degree to which embryonic stem peptide receptors (ESCs) represent generic properties of pluripotent founder cells in mammalian embryos is unresolved (Nichols and Smith, 2012; Smith, 2001). Mouse ESCs are the paradigmatic model. However, it is increasingly clear that there are diff
-
It is interesting to note that the commonly used hBMSC
2018-11-12

It is interesting to note that the commonly used hBMSC and hMSC marker, CD166, showed a higher expression in osteogenically differentiated tsa inhibitor compared with undifferentiated cells. This increase in expression was also recently demonstrated in hBMSCs undergoing both osteogenic and adipogeni
-
Acknowledgments We are indebted to the Citomics unit of the
2018-11-12

Acknowledgments We are indebted to the Citomics unit of the IDIBAPS for technical help. This work was supported by grants from the Spanish Ministry of Economia y CompetitividadBIO2011-30299-C02-02 and from CIDEM-Generalitat de CatalunyaVALTEC09-2-0047. and was developed at the Centro Esther Koplowi
16007 records 1045/1068 page Previous Next First page 上5页 10411042104310441045 下5页 Last page